D
Neurothera Labs Inc. NTLX.V
TSX
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2025 09/30/2025
Total Cash And Short-Term Investments 1,353.85% --
Total Receivables 71.11% --
Inventory -33.63% --
Prepaid Expenses -- --
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets 0.00% --
Total Current Assets 553.68% --

Total Current Assets 553.68% --
Net Property, Plant & Equipment -- --
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -20.89% --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets -- --
Total Assets 71.94% --

Total Accounts Payable 2,206.67% --
Total Accrued Expenses 75.66% --
Short-term Debt -- --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current -- --
Total Finance Division Other Current Liabilities 1,463.64% --
Total Other Current Liabilities 1,463.64% --
Total Current Liabilities 509.73% --

Total Current Liabilities 509.73% --
Long-Term Debt -- --
Short-term Debt -- --
Capital Leases -- --
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities -- --
Total Liabilities 955.31% --

Common Stock & APIC 351.16% --
Retained Earnings -19.78% --
Treasury Stock & Other -- --
Total Common Equity -82.91% --

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible -- --
Preferred Stock, Others -- --
Total Preferred Equity -- --

Total Common Equity -82.91% --
Total Preferred Equity -- --
Total Minority Interest -31.83% --
Total Equity -57.87% --